User and responsibility policy
The DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL website provides a wide range of information, services and data. The User assumes responsibility for the proper use of the website. This responsibility shall include:
- The veracity and legality of the information given by the User in the forms provided by DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL, in order to access specific contents or services offered by the website.
- The use of the information, services and data provided by DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL which is contrary to the provisions of the Terms stated herein, the Law, morality, good conduct or public order, or which could, in any other way, infringe upon the rights of third parties or adversely affect the actual operation of the website.
Links policy and liability exemptions
DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL shall not be held responsible for the content of the websites which the User can access through the links provided on its website and states that, under no circumstances, shall it examine or exert any kind of control over the content of other websites. Likewise, it will not guarantee the technical availability, accuracy, truthfulness, validity or legality of websites outside of its ownership which can be accessed through the links on its website.
DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL declares that it has taken all necessary measures to prevent any damages to its website’s Users which may arise from browsing its website. Consequently, DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL shall not be held responsible, under any circumstances, for any possible damages the User may suffer when browsing the Internet.
Contents related to the misistemainmune blog
Through the My Immune System blog, DIMI intends to offer information on topics related to health or other topics of interest to the user of the blog.
DIMI does not guarantee in any way the full applicability of the information, its accuracy or timeliness, or any other aspect of it, nor the continuity, applicability and uninterrupted operation of the services that it could offer through this blog.
The information contained in this blog has been reviewed and validated by the person responsible for the corresponding medical-pharmaceutical information and the communication department of the Labo’Life group and must be considered as general information and it must be taken into account that under no circumstances can it be used or construed as medical, legal or other advice. In addition, please take into account that some of the information or services contained on this website are exclusively intended for healthcare professionals.
This blog contains links to other servers over which DIMI has no control. Therefore, DIMI is not responsible in any way for the information or services, and in general, for what is contained therein, and cannot guarantee their legality, veracity or timeliness, or any other aspect thereof.
All the photographs where the image of people appears have been chosen for their promotional nature and are not related to the pathologies or medicines to which reference is made.
The comments published following each blog article are public in nature and are therefore visible to all users. The user must be aware that his publications will be visible to other users, and that he is therefore responsible for protecting his privacy.
Intellectual and industrial property
DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL, in its own right or as an assignee, is the owner of all intellectual and industrial property rights of its website, as well as all the elements contained therein (including, but not limited to, images, sound, audio, video, software or texts; trademarks or logos, colour combinations, structure and design, selection of materials used, computer programs necessary for its operation, access and use, etc.) owned by DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL. They will therefore be protected as intellectual property under the Spanish legal system, with both Spanish and European Union regulations being applicable in this field, as well as international treaties relating to the matter which have been signed by Spain.
All rights reserved. Under the provisions of articles 8 and 32.1, second paragraph, of the Intellectual Property Law, the reproduction, distribution and public communication, including any means of making available all or part of the content of this website, for commercial purposes, in any medium and by any technical means, is strictly prohibited without the express authorisation of DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL.
The User undertakes to respect the Intellectual and Industrial Property rights owned by DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL. You may view the website contents and even print, copy and store them on your computer’s hard disk, or any other physical media, provided it is solely and exclusively for your personal and private use.
The following sections of the website are exempt from this agreement: contents published in the website’s section “Press room” and the photos and videos in which specific authorisations are indicated by DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL other than those mentioned before. Specifically, this section refers to authorisations relating to materials that can be downloaded, used and reproduced in other public media, provided that it does not contradict the license or notice that the work may possess and that it is the one that prevails, that no such contents, images or videos are altered, and that it is expressly stated that they belong to Labo’Life’s group and therefore are protected by intellectual property rights. In addition, to reuse the information, the following conditions must also be met:
- Do not distort the meaning of the information
- Always quote the source of the information
- Mention the date of the last information update
Moreover, reuse could be limited by the protection of other priority rights, such as the protection of personal data, privacy or third-party intellectual property rights. Reuse of works protected by intellectual property can be formalised through the use of open-source licenses, such as those of Creative Commons, which grant specific rights to exploit these works. For the contents where this type of licenses is applied, reuse is allowed under the conditions established therein.
Under no circumstances will authorisation be granted for the use of logos, trademarks and distinctive symbols of Labo’Life’s group (or of DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL) in publications and websites which are not part of or sponsored by Labo’Life’s group (or DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL). These corporate graphic identity elements are the exclusive property of LABO’LIFE’s group (or DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL) and are protected by the applicable legislation currently in force.
In any case, both for those materials which have the authorisations to be reused and for those which do not have them, the User must refrain from deleting, altering, bypassing or manipulating any protection device or security system installed in the pages of DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL.
Legal actions, applicable legislation and jurisdiction
The relationship between the User and the provider shall be governed by the current legislation applicable in the Spanish territory. In the event of any dispute which may arise, the parties may submit their claims to arbitration or resort to the ordinary jurisdiction, complying with the relevant regulations on jurisdiction and competence. The official registered address of DESARROLLO INTERNACIONAL DE MICRO-INMUNOTERAPIA SL is in ILLES BALEARS, Spain.
Creative commons license – contents related to the blog
DIMI allows you the reproduction, distribution and public communication of the work and also its transformation to make derivative works, as long as it does not contradict the license or notice that a work may have and which is the one that prevails. We allow the reproduction, distribution, public communication and transformation to generate a derivative work, without any restriction as long as the owner of the rights is cited: DIMI.
The complete license can be consulted at http://creativecommons.org/licenses/by/3.0/es/
Help us improve this blog: firstname.lastname@example.org
Blog and news advertising policy
DIMI does not include third-party advertising on this website, carried out in any way.